CTVABasic Materials · Agricultural InputsThe 21 Wall Street analysts covering Corteva, Inc. hold a median 12-month price target of $95 — +24.9% from the last close. Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 65 of 100 as at 1 Aug 2026 — in the upper half.
Consensus tells you what everyone already believes. The model scores Corteva, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.
Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested
Volatility (98): The share price has been relatively steady.
Accruals (51): A large share of reported profit has not shown up as cash, or the balance sheet is expanding quickly — both tend to unwind.
Size (5): Larger than most of the companies we track — more scrutinised, less often mispriced.
The rank is the raw material. Whether the rules would actually own Corteva, Inc. — and when they’d sell — is the membership.
The bullish and bearish analyst opinions on CTVA, reported as data — targets and ratings, the market's view beside the model's.
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
The green dot is the last close — the median target sits +24.9% from it.
Of the 20 most recent actions, 8 moved their price target up and 0 moved it down.
| Date | Firm | Action | Rating | Target |
|---|---|---|---|---|
| 3 Aug 2026 | BMO Capital | Maintains | Outperform | $95 → $100 |
| 3 Aug 2026 | Citigroup | Maintains | Neutral | $85 → $86 |
| 3 Aug 2026 | JP Morgan | Maintains | Neutral | $77 → $83 |
| 3 Aug 2026 | UBS | Maintains | Neutral | $86 → $89 |
| 23 July 2026 | Oppenheimer | Maintains | Outperform | $89 → $95 |
| 21 July 2026 | RBC Capital | Maintains | Outperform | $97 → $103 |
| 20 July 2026 | B of A Securities | Maintains | Buy | $90 → $96 |
| 14 July 2026 | Mizuho | Maintains | Outperform | — |
| 14 July 2026 | Mizuho | Maintains | Outperform | $96 → $97 |
| 2 July 2026 | Mizuho | Maintains | Outperform | — |
| 11 June 2026 | Barclays | Maintains | Overweight | — |
| 9 June 2026 | UBS | Maintains | Neutral | — |
| 28 May 2026 | Morgan Stanley | Maintains | Overweight | — |
| 7 May 2026 | Citigroup | Maintains | Neutral | — |
| 7 May 2026 | UBS | Maintains | Neutral | — |
| 24 Apr 2026 | RBC Capital | Maintains | Outperform | — |
| 22 Apr 2026 | Oppenheimer | Maintains | Outperform | — |
| 21 Apr 2026 | Wells Fargo | Maintains | Overweight | — |
| 9 Apr 2026 | UBS | Maintains | Neutral | — |
| 31 Mar 2026 | Argus Research | Maintains | Buy | — |
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.
A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.
Cheaper than 17% of US stocks
Cheaper than 43% of US stocks
Cheaper than 45% of US stocks
Cheaper than 29% of US stocks
Higher than 27% of US stocks
Higher than 25% of US stocks
Higher than 66% of US stocks
Higher than 88% of US stocks
Higher than 62% of US stocks
Higher than 52% of US stocks
Higher than 74% of US stocks
Higher than 21% of US dividend payers
Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.
The nearest names by industry and size, scored by the same model — like for like.
| Company | Market cap | TKN rank |
|---|---|---|
| CTVACorteva, Inc. | $50.9B | 65 |
| NTRNutrien Ltd. | $33.2B | 87 |
| CFCF Industries Holdings, Inc. | $19.7B | 96 |
| MOSThe Mosaic Co. | $7.0B | 28 |
| ICLICL Group Ltd. | $6.5B | 51 |
| SMGScotts Miracle-Gro Co. | $3.8B | 93 |
| NUENucor Corp.* | $58.9B | 95 |
* Nearest Basic Materials names by size — few agricultural inputs companies of this scale trade in the US universe.
Computed off the Friday close and sent before the US open.
Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. CTVA appears on the weeks it earns a place.
Corteva released its Q2 2026 earnings call transcript via Seeking Alpha, covering the company's quarterly financial results and operational discussion.
Why it matters — Investors and analysts tracking CTVA rely on earnings call transcripts for detailed insights into the company's financial performance and strategic outlook.
Corteva raised its full-year outlook after reporting higher first-half sales, earnings and margins, citing demand for seed technologies, growth in new crop-protection products, licensing income and cost discipline. The company also said it remains on schedule to separate its businesses on Oct. 1, with its advanced seed and genetics company expected to operate as Vylor.
Why it matters — A CTVA watcher would care because the raised outlook and progress on the business separation signal operational momentum and a key strategic milestone, both of which are closely watched by investors.
Zacks Investment Research published a piece asking whether Corteva, Inc. (CTVA) qualifies as a top momentum stock pick. No specific news or analysis was provided in the excerpt.
Why it matters — CTVA watchers would care because momentum-focused coverage can influence investor perception and trading interest in the stock.
Corteva reported Q2 earnings per share that beat estimates, while sales fell 1% year over year. The company also raised its 2026 outlook, citing improved Seed pricing and productivity gains that lifted margins.
Why it matters — CTVA watchers would note that the raised 2026 outlook signals management's confidence in the company's margin trajectory despite a slight sales decline.
A Seeking Alpha article notes that Corteva is a global leader in pure agri-tech with a focus on R&D for seed genetics and crop solutions, and acknowledges that its stock has significantly outperformed the broader market and ETF peers since the author's prior reviews.
Why it matters — CTVA watchers would note the article's recognition that Corteva's strong fundamentals and execution have driven outperformance, though upside is described as limited.
The 21 Wall Street analysts covering Corteva, Inc. have a median 12-month price target of $95, with estimates ranging from $77 to $103. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.
Of the 21 analysts covering Corteva, Inc., 15 rate it a Buy, 6 a Hold and 0 a Sell. Ticker Nerd's systematic factor model ranks Corteva, Inc. 65 out of 100 across roughly 4,600 US stocks as at 1 Aug 2026. None of this is personal advice — it does not consider your circumstances.
As at 1 Aug 2026, Corteva, Inc. ranks 65 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Volatility (98 of 100).
No one can know that. What the data says: the median 12-month target from 21 analysts implies +24.9% from the last close, and Ticker Nerd's factor model ranks Corteva, Inc. 65 out of 100 as at 1 Aug 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.
No analyst covering Corteva, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for CTVA are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $77 to $103 over the next 12 months.
Corteva, Inc. returned +7.9% over the 12 months to 3 Aug 2026, with dividends reinvested. Past performance does not indicate future returns.
Corteva Inc. is an agricultural inputs company that provides seed and crop protection solutions to farmers and agricultural businesses worldwide.
The most recent item we track (Seeking Alpha, 31 July 2026): "Corteva, Inc. (CTVA) Q2 2026 Earnings Call Transcript". Corteva released its Q2 2026 earnings call transcript via Seeking Alpha, covering the company's quarterly financial results and operational discussion.
Corteva Inc. is an agricultural inputs company that provides seed and crop protection solutions to farmers and agricultural businesses worldwide. The company focuses on improving crop productivity and protecting yields through a broad portfolio that includes advanced seeds, herbicides, insecticides, fungicides, seed treatments, and nitrogen management products. Its offerings support a range of major crops and are used across row-crop and specialty agriculture markets. Corteva Inc. plays an important role in the global food supply chain by helping growers manage pests, disease, and weed pressure while supporting more efficient farm operations. Headquartered in Indianapolis, Indiana, Corteva Inc. operates as a dedicated agriscience business with products and services tailored to modern agriculture.
CEO Mr. Charles Victor Magro B.Sc. (Chem), MBA · 21,500 employees · United States · https://www.corteva.com